Tofajak-IN XR 5 Mg

Medicine Overview

Tofajak-IN XR 5 mg is an extended-release tablet containing 5 mg of tofacitinib, designed for the effective management of autoimmune diseases such as rheumatoid arthritis and psoriatic arthritis. Its extended-release formulation ensures consistent blood levels, providing sustained relief from inflammation, joint pain, and stiffness throughout the day. Tofajak-IN XR 5 mg works by selectively inhibiting Janus kinase (JAK) enzymes, helping to regulate the immune response and reduce disease progression. Ideal for adults requiring long-term treatment, it improves mobility and quality of life with convenient once-daily dosing. Trusted for its safety and effectiveness, Tofajak-IN XR 5 mg offers advanced control of chronic inflammatory conditions.